The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
125287722 12528772 2 F 20150408 20160816 20160705 20160825 EXP IL-SA-2015SA052472 AVENTIS 66.00 YR E M Y 90.00000 KG 20160825 MD IL IL

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
125287722 12528772 1 PS PLAVIX CLOPIDOGREL BISULFATE 1 Oral Y UNKNOWN 20839 300 MG QD
125287722 12528772 2 SS PLAVIX CLOPIDOGREL BISULFATE 1 Oral Y UNKNOWN 20839 75 MG QD
125287722 12528772 3 C FENOFIBRATE. FENOFIBRATE 1 Oral 0
125287722 12528772 4 C SPIRONOLACTONE. SPIRONOLACTONE 1 Oral 0
125287722 12528772 5 C SLOW DERALIN 2 Oral 0 CAPSULE
125287722 12528772 6 C ASPIRIN. ASPIRIN 1 Oral 0 TABLET
125287722 12528772 7 C RAFASSAL 2 Rectal 0 SUPPOSITORY
125287722 12528772 8 C OMEPRADEX OMEPRAZOLE 1 Oral 0
125287722 12528772 9 C VITAMIN D CHOLECALCIFEROL 1 Oral 0
125287722 12528772 10 C MAGNESIUM MAGNESIUM 1 Oral 0
125287722 12528772 11 C DEPALEPT VALPROIC ACID 1 Oral 0 TABLET
125287722 12528772 12 C TARGIN NALOXONE HYDROCHLORIDEOXYCODONE HYDROCHLORIDE 1 Oral TOTAL DAILY DOSE: 10/5 MG 0 TABLET
125287722 12528772 13 C TARGIN NALOXONE HYDROCHLORIDEOXYCODONE HYDROCHLORIDE 1 Oral TOTAL DAILY DOSE: 10/5 MG 0 TABLET
125287722 12528772 14 C DISOTHIAZIDE 2 Oral 0 12.5 MG TABLET QD
125287722 12528772 15 C CRESTOR ROSUVASTATIN CALCIUM 1 Oral 0 20 MG TABLET QD
125287722 12528772 16 C TRITACE RAMIPRIL 1 Oral 0 5 MG CAPSULE QD

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
125287722 12528772 4 Hypertension
125287722 12528772 5 Hypertension
125287722 12528772 6 Cardiovascular disorder
125287722 12528772 8 Prophylaxis
125287722 12528772 10 Prophylaxis

Outcome of event

Event ID CASEID OUTC COD
125287722 12528772 HO
125287722 12528772 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
125287722 12528772 Carotid arteriosclerosis
125287722 12528772 Confusional state
125287722 12528772 Depression
125287722 12528772 Ear infection
125287722 12528772 Lacunar stroke
125287722 12528772 Rash
125287722 12528772 Thrombocytopenia

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
125287722 12528772 1 20150408 20150408 0
125287722 12528772 2 20150409 20150416 0
125287722 12528772 3 20140529 0
125287722 12528772 4 2011 20150408 0
125287722 12528772 5 2003 0
125287722 12528772 6 1998 20150407 0
125287722 12528772 7 1990 20150407 0
125287722 12528772 8 2003 20150407 0
125287722 12528772 9 20130729 0
125287722 12528772 10 20130913 0
125287722 12528772 11 20140805 0
125287722 12528772 12 20150409 20150416 0
125287722 12528772 13 20150308 20150408 0